Integrated IVD Provider Yashraj Biotechnology is a long-standing manufacturer of native and recombinant antigens and antibodies for the global in vitro diagnostics industry, with ISO 13485:2016 and ISO 9001:2015 certifications, enabling reliable supply of high-purity biomarkers for diagnostic assays.

Large-Scale Capacities The company operates a 200,000 sq. ft. manufacturing footprint across four sites, leveraging mammalian and microbial expression systems plus a goat polyclonal facility, supporting scale, batch-to-batch consistency, and diverse product formats.

Clinical Sample Access YBL’s vertical integration through a vast network of Indian hospitals provides access to diverse native human samples for antigen purification, enabling physiologically relevant materials and enhanced validation for partners’ IVD products.

Global Partnering With over 25 years of experience and a focus on reliable raw materials for leading global IVD manufacturers, there are clear opportunities for strategic supply partnerships, co-development, and private-label collaborations in oncology, cardiovascular, inflammation, infectious disease, and metabolic markers.

Growth Signals Current revenue ambition falls in the mid-market range; combined with certifications and capabilities, YBL is positioned to target mid-to-large global diagnostics players seeking high-purity native antigens and consistent reagents, as well as niche biomarkers in high-demand panels.